Showing results (1931-1940 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|October 1, 2021
The clinical significance of tertiary lymphoid structure and its relationship with peripheral blood characteristics in patients with surgically resected non-small cell lung cancer: a single-center, retrospective studyMitsuro Fukuhara, Satoshi Muto, Sho Inomata, et al.
Cancer Immunology, Immunotherapy : CII|October 13, 2021
Assessment of immune status of laryngeal squamous cell carcinoma can predict prognosis and guide treatmentXueying Wang, Kui Cao, Erliang Guo, et al.
Cancer Immunology, Immunotherapy : CII|September 24, 2021
Defective NK cell expansion, cytotoxicity, and lack of ability to differentiate tumors from a pancreatic cancer patient in a long term follow-up: implication in the progression of cancerKawaljit Kaur, Meng-Wei Ko, Franklin Chen, et al.
Cancer Immunology, Immunotherapy : CII|September 24, 2021
Lenvatinib with or without immune checkpoint inhibitors for patients with unresectable hepatocellular carcinoma in real-world clinical practiceKang Chen, Wei Wei, Lei Liu, et al.
Cancer Immunology, Immunotherapy : CII|October 18, 2019
Clinicopathologic significance of human leukocyte antigen class I expression in patients with stage II and III gastric cancerYujun Park, Jiwon Koh, Yoonjin Kwak, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2021
Highly differential count of circulating and tumor infiltrating immune cells in patients with non-HCV/non-HBV hepatocellular carcinomaMarkus Bo Schoenberg, Tong Zhu, Jingcheng Hao, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal modelM Ripamonti, S Canevari, S Ménard, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
Adoptive immunity in mice challenged with L1210/DTIC clonesG Canti, L Ricci, O Marelli, et al.
Cancer Immunology, Immunotherapy : CII|April 23, 2022
Tcf-1 protects anti-tumor TCR-engineered CD8+ T-cells from GzmB mediated self-destructionBrendan Zangari, Takemasa Tsuji, Junko Matsuzaki, et al.
Cancer Immunology, Immunotherapy : CII|April 26, 2022
Incidence of hepatotoxicity associated with addition of immune checkpoint blockade to systemic solid tumor therapy: a meta-analysis of phase 3 randomized controlled trialsYu Fujiwara, Nobuyuki Horita, Matthew Harrington, et al.
Pageof 652